Novel mutation signatures in the prognosis of EGFR-TKIs targeted therapy for non-small cell lung cancer patients based on the 1000-gene panel sequencing / Hui Zhang ... [et al.]. -- ilustr., aj fareb., obr., tab. -- Bibliogr. odkazy - Res. angl.

In Neoplasma : journal of experimental and clinical oncology. -- Bratislava : AEPress, 2022. -- s. 251-490. -- ISSN 0028-2685. -- Vol. 69, no. 2 (2022), s. 352-360

1. karcinóm pľúc, nemalobunkový - genetika 2. receptory erbB - antagonisty a inhibítory 3. gény 4. mutácia 5. analýza DNA, mutačná 6. prognóza

I. Zhang, Hui
II. Neoplasma : journal of experimental and clinical oncology. -- Vol. 69, no. 2 (2022), s. 352-360

vyhodnotenie súboru pacientov